◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocks0-9 › 2190

Zylox-Tonbridge Medical Technology Co., Ltd. (2190) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Devices · DATA UPDATED 2026-08-11

Zylox-Tonbridge Medical Technology Co., Ltd. (2190) operates in the Medical Devices industry and is headquartered in Hangzhou, China with about 925 employees. Its market capitalization is roughly CNY 7 billion.

Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices in the People's Republic of China and internationally.

Interactive charts & full statements →

2190 Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total RevenueCNY 782MCNY 528MCNY 334MCNY 178M
Gross ProfitCNY 560MCNY 385MCNY 253MCNY 132M
Operating Income (EBIT)CNY 77M(CNY 144M)(CNY 222M)(CNY 218M)
Net IncomeCNY 100M(CNY 79M)(CNY 114M)(CNY 200M)

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

2190 Free Cash Flow History

2190 Balance Sheet History

Balance sheet2024-12-312023-12-312022-12-312021-12-31
Total AssetsCNY 3.5BCNY 3.4BCNY 3.3BCNY 3.2B
Total LiabilitiesCNY 352MCNY 328MCNY 160MCNY 104M

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 2190 viewer.

Other Companies in Medical Devices

← 2189All “0-9” companies2192 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.